TY - JOUR
T1 - Methodological Standards for the Design, Implementation, and Analysis of Randomized Trials in Cardiac Surgery
T2 - A Scientific Statement from the American Heart Association
AU - Gaudino, Mario
AU - Chikwe, Joanna
AU - Bagiella, Emilia
AU - Bhatt, Deepak L.
AU - Doenst, Torsten
AU - Fremes, Stephen E.
AU - Lawton, Jennifer
AU - Masterson Creber, Ruth M.
AU - Sade, Robert M.
AU - Zwischenberger, Brittany A.
N1 - Publisher Copyright:
© 2022 Lippincott Williams and Wilkins. All rights reserved.
PY - 2022/1/25
Y1 - 2022/1/25
N2 - Cardiac surgery presents specific methodological challenges in the design, implementation, and analysis of randomized controlled trials. The purposes of this scientific statement are to review key standards in cardiac surgery randomized trial design and implementation, and to provide recommendations for conducting and interpreting cardiac surgery trials. Recommendations include a careful evaluation of the suitability of the research question for a clinical trial, assessment of clinical equipoise, feasibility of enrolling a representative patient cohort, impact of practice variations on the safety and efficacy of the study intervention, likelihood and impact of crossover, and duration of follow-up. Trial interventions and study end points should be predefined, and appropriate strategies must be used to ensure adequate deliverability of the trial interventions. Every effort must be made to ensure a high completeness of follow-up; trial design and analytic techniques must be tailored to the specific research question and trial setting.
AB - Cardiac surgery presents specific methodological challenges in the design, implementation, and analysis of randomized controlled trials. The purposes of this scientific statement are to review key standards in cardiac surgery randomized trial design and implementation, and to provide recommendations for conducting and interpreting cardiac surgery trials. Recommendations include a careful evaluation of the suitability of the research question for a clinical trial, assessment of clinical equipoise, feasibility of enrolling a representative patient cohort, impact of practice variations on the safety and efficacy of the study intervention, likelihood and impact of crossover, and duration of follow-up. Trial interventions and study end points should be predefined, and appropriate strategies must be used to ensure adequate deliverability of the trial interventions. Every effort must be made to ensure a high completeness of follow-up; trial design and analytic techniques must be tailored to the specific research question and trial setting.
KW - AHA Scientific Statements
KW - equivalence trials
KW - randomized controlled trials
KW - surveys and questionnaires
KW - therapeutic equipoise
KW - thoracic surgery
UR - http://www.scopus.com/inward/record.url?scp=85123879026&partnerID=8YFLogxK
U2 - 10.1161/CIR.0000000000001037
DO - 10.1161/CIR.0000000000001037
M3 - Review article
C2 - 34865513
AN - SCOPUS:85123879026
SN - 0009-7322
VL - 145
SP - E129-E142
JO - Circulation
JF - Circulation
IS - 4
ER -